Trials / Completed
CompletedNCT03428633
Thoracic Paravertebral Blocks in Open Nephrectomy
Thoracic Paravertebral Blocks in Open Nephrectomy. A Prospective, Randomized Study of Block Efficacy and Influence on Oxidative Stress and Patient Outcome.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Asklepieion Voulas General Hospital · Other Government
- Sex
- All
- Age
- 14 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
60 patients ASA I-III, undergoing open nephrectomy will be randomly assigned into one of two groups, namely group A (n=30), where a thoracic paravertebral block will be performed preoperatively and a paravertebral catheter for continuous and patient controlled bolus local anesthetic (ropivacaine) doses will be inserted and group B (n=30) where morphine IV will be administered at the beginning and the end of operation and postoperatively through patient controlled IV doses. NRS scores in static and dynamic conditions, complications, patient satisfaction, oxidative stress (through lactic acid, superoxide dismutase, malondialdehyde) and NGAL pre- and postoperatively, will be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | Paravertebral block using ropivacaine preoperatively and postoperatively |
| DRUG | Morphine | Morphine intraoperatively and postoperatively |
Timeline
- Start date
- 2018-03-09
- Primary completion
- 2021-02-01
- Completion
- 2023-02-01
- First posted
- 2018-02-09
- Last updated
- 2023-10-13
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03428633. Inclusion in this directory is not an endorsement.